These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24396653)

  • 1. Anaplastic thyroid carcinoma following radioactive iodine therapy for graves' disease.
    Kim SH; Kim HY; Jung KY; Choi DS; Kim SG
    Endocrinol Metab (Seoul); 2013 Mar; 28(1):61-4. PubMed ID: 24396653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy.
    Aoyama M; Takizawa H; Tsuboi M; Nakagawa Y; Tangoku A
    Endocr J; 2017 Dec; 64(12):1143-1147. PubMed ID: 28883260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' disease and thyroid cancer.
    Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive Iodine: A Living History.
    Daniels GH; Ross DS
    Thyroid; 2023 Jun; 33(6):666-673. PubMed ID: 37307104
    [No Abstract]   [Full Text] [Related]  

  • 5. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease.
    Yunusa GH; Kotze T; Brink A
    Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
    Kaplowitz PB; Jiang J; Vaidyanathan P
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves' disease.
    Cohen RZ; Felner EI; Heiss KF; Wyly JB; Muir AB
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):319-25. PubMed ID: 26656610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Health by Graves' Disease Management Modality - Surgery Versus Radioactive Iodine Versus Antithyroid Medications: A Network Meta-Analysis.
    Issa PP; Hussein M; Omar M; Munshi R; Attia AS; Buti Y; Aboueisha M; Shama M; Toraih E; Kandil E
    J Surg Res; 2023 Mar; 283():266-273. PubMed ID: 36423475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine needle aspiration biopsy of the thyroid gland in patients with prior Graves' disease treated with radioactive iodine. Morphologic findings and potential pitfalls.
    Centeno BA; Szyfelbein WM; Daniels GH; Vickery AL
    Acta Cytol; 1996; 40(6):1189-97. PubMed ID: 8960027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
    Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid Isthmus Length and Iodine Turnover as Predictors of Successful Radioactive Iodine Therapy in Patients with Graves' Disease.
    Park SH; Hwang S; Han S; Shin DY; Lee EJ
    Int J Endocrinol; 2017; 2017():7354673. PubMed ID: 29358949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves' disease patients with thyrotoxic periodic paralysis.
    Karndumri K; Thewjitcharoen Y; Chatchomchuan W; Porramatikul S; Krittiyawong S; Wanothayaroj E; Butadej S; Nakasatien S; Rajatanavin R; Himathongkam T
    J Clin Transl Endocrinol; 2020 Sep; 21():100235. PubMed ID: 32953456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated
    Wong KK; Shulkin BL; Gross MD; Avram AM
    Clin Diabetes Endocrinol; 2018; 4():20. PubMed ID: 30505461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppurative Lymphadenitis after Radioactive Iodine Therapy for Graves' Disease: A Rare Complication?
    Wong SHJ
    Eur Thyroid J; 2019 Dec; 8(6):324-327. PubMed ID: 31934559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.
    Wartofsky L
    Thyroid; 1997 Apr; 7(2):213-6. PubMed ID: 9133687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of antithyroid drug treatment may predict weight gain after radioactive iodine therapy in patients with Graves' disease.
    Yotsapon T; Waralee C; Hussamon P; Panita S; Siriwan B; Soontaree N; Ekgaluck W; Rajata R; Thep H
    Heliyon; 2022 May; 8(5):e09471. PubMed ID: 35615430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium as an alternative option in thionamide-resistant Graves' disease.
    Chung YK; Wong LM
    Clin Pediatr Endocrinol; 2023; 32(3):168-173. PubMed ID: 37362160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Graves' Disease Following Near-Total Thyroidectomy: A Case Report and Literature Review.
    Menon LP; Naqvi S; Maradana J; Edem D
    Cureus; 2024 Jan; 16(1):e52260. PubMed ID: 38352081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.